Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia-Reference-Cited by-同舟云学术

Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia

Published:2016-01-26 Issue:1 Volume:11 Page:e0147545
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Ye,Wu SiJing,Luo Dan,Zhou JianFeng,Li DengJu

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia;E Lengfelder;Leukemia,2012

2. The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia;KA Breen;Br J Haematol,2012

3. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint;A Biondi;Leukemia,1995

4. Acute promyelocytic leukemia: from highly fatal to highly curable;ZY Wang;Blood,2008

5. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol;MS Tallman;Blood,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombosis in Myeloid Malignancies: From CHIP to AML;Cardiovascular & Hematological Disorders-Drug Targets;2024-03

2. The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management;Cancers;2023-07-03

3. Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience.;Mediterranean Journal of Hematology and Infectious Diseases;2023-01-01

4. Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia;Clinical and Applied Thrombosis/Hemostasis;2022-01

5. Co-delivery of all-trans-retinoic acid and docetaxel in drug conjugated polymeric nanoparticles: Improving controlled release and anticancer effect;Materials Today Communications;2020-12